Novel substituted 7-deazapurine ribonucleosides for therapeutic uses

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61388963%3A_____%2F16%3A00471699" target="_blank" >RIV/61388963:_____/16:00471699 - isvavai.cz</a>
Result on the web
<a href="https://worldwide.espacenet.com/publicationDetails/biblio?II=0&ND=3&adjacent=true&locale=en_EP&FT=D&date=20160225&CC=AU&NR=2014277740B1&KC=B1#" target="_blank" >https://worldwide.espacenet.com/publicationDetails/biblio?II=0&ND=3&adjacent=true&locale=en_EP&FT=D&date=20160225&CC=AU&NR=2014277740B1&KC=B1#</a>
DOI - Digital Object Identifier
—

Result language
angličtina
Original language name
Novel substituted 7-deazapurine ribonucleosides for therapeutic uses
Original language description
The invention provides compounds of formula I, wherein R and R' have values defined in the specification and a pharmaceutically acceptable salt thereof, or an optical isomer thereof, or a mixture of optical isomers, as well as compositions comprising such 5 compounds and therapeutic methods that utilize such compounds and/or compositions.
Czech name
—
Czech description
—

Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2016
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Patent/design ID
AU2014277740
Publisher
AU001 -
Publisher name
IP Australia
Place of publication
Phillip ACT
Publication country
AU - AUSTRALIA
Date of acceptance
Feb 25, 2016
Owner name
Ústav organické chemie a biochemie AV ČR, v. v. i. - Univerzita Palackého v Olomouci
Method of use
A - Výsledek využívá pouze poskytovatel
Usage type
A - K využití výsledku jiným subjektem je vždy nutné nabytí licence

Similar results(10)